All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news

RSS

← First12345...701Next →

hiv & aids news selected from other sources

  • PrEP
    Does PrEP = a new gay sexual revolution?
    Bay Area Reporter | 4 hours ago

    Even though many health professionals portray PrEP as being "just another tool" to curtail the HIV epidemic, the charged rhetoric used by those for or against it – terms such as "party drug" or "Truvada whore" – suggests otherwise. As noted by a New York Times headline, PrEP raises the dramatic possibility of a new "sexual revolution" for gay men. While the idea frightens and even outrages many people, some advocates (including an increasingly vocal new generation of gay activists) are explicitly embracing the idea of less fear and more sexual choice, if not outright freedom.

  • Hepatitis C treatment
    In patients co-infected with HIV, combination antiretroviral therapy helps treat HCV
    HIV / AIDS News From Medical News Today | 22 hours ago

    Treatment of HIV patients co-infected with the hepatitis C virus (HCV) with an anti-retroviral drug therapy not only tackles HIV, but also reduces HCV replication, according to a new study lead by a University of Cincinnati researcher. The results were published in Science Translational Medicine.

  • Condoms and lubricant
    Young people speak out against stigma of youth condom use
    Key Correspondents | 22 hours ago

    Young people around the world are not receiving clear messages or support to use condoms to prevent HIV infection, according to delegates at the AIDS 2014 conference.

  • Starting treatment
    Men Who Have Sex With Men Getting Treatment Sooner
    MedPage Today | 22 hours ago

    Long-term trends indicate that European men who have sex with men are seeking treatment for HIV at earlier stages of their disease, researchers reported here.

  • Pharmaceutical industry
    Gilead's Sovaldi soars with sales of $3.48 billion
    Pharma Times | 22 hours ago

    An excellent day for Gilead Sciences has seen the US biotech post record-breaking sales of its hepatitis C pill Sovaldi and approval in the USA for Zydelig to treat three types of blood cancer.

  • Hepatitis C treatment
    Activists Hold Die-In to Protest High Price of Gilead’s Hepatitis C Drug
    Treatment Action Group | 22 hours ago

    Treatment activists at the 20th International AIDS Conference held a die-in to protest the exorbitant pricing of Sovaldi (sofosbuvir), Gilead’s new hepatitis C virus (HCV) drug. As Gregg Alton, Gilead’s executive vice president of corporate and medical affairs, spoke, activists brought him a liver on a silver platter while chanting “Pills Cost Pennies, Greed Costs Lives,” “Shame, Shame, Shame,” and “Pharma Greed Kills.” Their signs said, “Wanted: Crimes Against Access,” “Hep C Criminal,” and “Gilead Kills” as the O’Jay’s “For the Love of Money” blared in the background.

  • The Medicines Patent Pool (MPP) broadens collaboration with Gilead Sciences: Signs licence for Phase III medicine tenofovir alafenamide (TAF)
    Medicines Patent Pool | 22 hours ago

    The licence will allow manufacturers in India and China to develop generic versions of TAF for 112 countries that are home to more than 92% of people living with HIV in the developing world.

  • Finance and funding
    Bob Geldof slams wealthy countries over 'disgraceful' lack of HIV funding
    ABC News | 24 July 2014

    The Live Aid founder said there had been incredible advances in the fight against HIV and AIDS in the past 30 years, but that final steps were the most crucial.

  • Religion and faith
    Papua New Guinean revivalist churches push dangerous campaign for 'faith-healing' of AIDS
    ABC News | 24 July 2014

    Revivalist churches in Papua New Guinea are promoting prayer as a substitute for medication to those with HIV, according to human rights groups.

  • Access to medicines and treatment
    Maximizing the benefits of antiretroviral therapy for key populations
    International AIDS Society | 24 July 2014

    “Maximizing the benefits of ART for key populations” grew out of discussions between the Key Affected Populations and Treatment as Prevention Working Groups of the International AIDS Society. The two groups agreed that given the rapidly changing treatment and prevention landscape in HIV, there was a need to consider a range of issues affecting treatment access, prevention choices, and the implications of new guidelines for key populations.

← First12345...921Next →

Hepatitis C news

WHO recommends global use of newest hepatitis C drugs, urges price reductions.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Treatment as prevention

No-one with an undetectable viral load, gay or heterosexual, transmits HIV in two years of PARTNER study.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.